PREVENTION OF PREGNANCY COMPLICATIONS BY NOBLE GAS ADMINISTRATION

    公开(公告)号:US20180055876A1

    公开(公告)日:2018-03-01

    申请号:US15690020

    申请日:2017-08-29

    IPC分类号: A61K33/00 A61K9/00

    摘要: Disclosed are means of preventing, reducing and/or treating pregnancy associated complications by administration of Noble Gas mixtures, directly by inhalation, or by other means of direct or indirect introduction, with the intended effect of reducing immunological/inflammatory events associated with said complications. In one embodiment the invention teaches the modulation of the maternal-fetal unit from a Th1/Th17 predisposition towards a Th2/Treg environment by inhalation of a combination of 30% xenon gas admixed with air, or combinations of medical grade oxygen and nitrogen.

    NOBLE GAS NEUROPROTECTION AND NEUROREGENERATION FROM TREATMENT RELATED NEUROTOXICITY

    公开(公告)号:US20170341980A1

    公开(公告)日:2017-11-30

    申请号:US15610362

    申请日:2017-05-31

    IPC分类号: C04B22/00 C01B21/24 A61K33/00

    摘要: Disclosed are means of inducing neuroregeneration and/or neuroprotection in patients with damage to the nervous system. In one embodiment, Noble Gas containing compositions are administered to a patient suffering from a neurological injury, said therapy is administered alone, or in combination with other therapies useful in the induction of neuronal protection/stimulation of neurogenesis. In one specific embodiment, patients are treated with Noble Gas compositions to restore neural function subsequent to radiation therapy or chemotherapy for neoplasia of the brain. In another embodiment, Noble Gas compositions are administered prior to, concurrent with or after radiation and chemotherapy in order to induce a protective effect on non-malignant cells without substantially interfering with efficacy of radiation and chemotherapy.

    Augmentation of antiinflammatory, immunomodulatory, and regenerative processes in amyotrophic lateral sclerosis using xenon and noble gas combinations

    公开(公告)号:US10376539B2

    公开(公告)日:2019-08-13

    申请号:US15598268

    申请日:2017-05-17

    摘要: Disclosed are methods of inhibiting progression, stabilizing and reversing amyotrophic lateral sclerosis and neuromuscular degenerative diseases including spinal muscular atrophy, by administration of xenon, or noble gas compositions at a sufficient frequency and concentration to evoke anti-inflammatory, immunomodulatory, and regenerative processes in a patient in need of therapy. In one embodiment, xenon is administered as a pharmaceutical preparation at a concentration of 5 to 90% by volume, more preferably for certain embodiments, at 5 to 30% by volume, wherein said pharmaceutical preparation additionally contains oxygen, argon, nitrogen and/or air. In other embodiments argon is utilized together, or as a replacement for xenon. Furthermore, the use of xenon and/or other noble gas combinations are disclosed for augmentation of therapies that augment endogenous regenerative cells.

    NOBLE GAS AUGMENTATION OF REGENERATIVE CELL ACTIVITY

    公开(公告)号:US20170281685A1

    公开(公告)日:2017-10-05

    申请号:US15465514

    申请日:2017-03-21

    IPC分类号: A61K35/28 C12N5/0775

    摘要: The current invention discloses compositions of matter, therapeutic protocols, and combination therapies utilizing previously unknown activity of Xenon alone or in combination with other Noble gases to augment therapeutic activity of regenerative cells, in one embodiment said regenerative cells comprising of mesenchymal stem cells. In one embodiment the invention provides use of xenon-pretreatment of cells prior to in vivo application in order to allow for enhanced efficacy of said cells. In other embodiments xenon alone, or in combination with other gases is utilized to modulate regenerative activity of cells in vivo.

    NOBLE GAS TREATMENT OF ALZHEIMER'S DISEASE AND TAUPATHIES

    公开(公告)号:US20170196906A1

    公开(公告)日:2017-07-13

    申请号:US15402177

    申请日:2017-01-09

    IPC分类号: A61K33/00 A61K9/00

    摘要: The invention discloses means of utilizing Noble Gases for inhibition of pathogenic processes associated with Alzheimer's Disease progression, as well as reversal of Alzheimer's Disease. In one embodiment compositions containing xenon gas are administered alone or together with therapeutic interventions for treatment of Alzheimer's Disease. In another embodiment, taupathies such as chronic traumatic encephalopathy are treated by administration of xenon or Noble Gas containing mixtures.